These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 22688351)
1. Wilms' tumor gene 1: a possible new proangiogenic factor in Hodgkin lymphoma. Vadasz Z; Shasha-Lavsky H; Nov Y; Bejar J; Lurie M; Tadmor T; Attias D Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):177-80. PubMed ID: 22688351 [TBL] [Abstract][Full Text] [Related]
2. WT1 expression correlates with angiogenesis in endometrial cancer tissue. Dohi S; Ohno S; Ohno Y; Kyo S; Soma G; Sugiyama H; Inoue M Anticancer Res; 2010 Aug; 30(8):3187-92. PubMed ID: 20871039 [TBL] [Abstract][Full Text] [Related]
3. Wilms' tumor gene (WT1) expression correlates with vascular epithelial growth factor (VEGF) in newly acute leukemia patients undergoing chemotherapy. Iranparast S; Assarehzadegan MA; Heike Y; Hossienzadeh M; Khodadadi A Asian Pac J Cancer Prev; 2014; 15(21):9217-23. PubMed ID: 25422204 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of angiogenic cytokines and their receptors in reactive benign lymph nodes and non-Hodgkin lymphoma. Ho CL; Sheu LF; Li CY Ann Diagn Pathol; 2003 Feb; 7(1):1-8. PubMed ID: 12616467 [TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells. Graham K; Li W; Williams BR; Fraizer G Gene Expr; 2006; 13(1):1-14. PubMed ID: 16572586 [TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Boublikova L; Kalinova M; Ryan J; Quinn F; O'Marcaigh A; Smith O; Browne P; Stary J; McCann SR; Trka J; Lawler M Leukemia; 2006 Feb; 20(2):254-63. PubMed ID: 16341043 [TBL] [Abstract][Full Text] [Related]
7. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes. Wróel T; Mazur G; Dziegiel P; Jeleń M; Szuba A; Kuliczkowski K; Zabel M Folia Histochem Cytobiol; 2006; 44(1):43-7. PubMed ID: 16584091 [TBL] [Abstract][Full Text] [Related]
8. VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells. Cash J; Korchnak A; Gorman J; Tandon Y; Fraizer G Oncol Rep; 2007 Jun; 17(6):1413-9. PubMed ID: 17487399 [TBL] [Abstract][Full Text] [Related]
9. Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma. Passam FH; Alexandrakis MG; Kafousi M; Fotinou M; Darivianaki K; Tsirakis G; Roussou PA; Stathopoulos EN; Siafakas NM Pathol Res Pract; 2009; 205(1):11-20. PubMed ID: 18950958 [TBL] [Abstract][Full Text] [Related]
10. Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C. Kadowaki I; Ichinohasama R; Harigae H; Ishizawa K; Okitsu Y; Kameoka J; Sasaki T Br J Haematol; 2005 Sep; 130(6):869-77. PubMed ID: 16156857 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Barragán E; Cervera J; Bolufer P; Ballester S; Martín G; Fernández P; Collado R; Sayas MJ; Sanz MA Haematologica; 2004 Aug; 89(8):926-33. PubMed ID: 15339675 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors. Amini Nik S; Hohenstein P; Jadidizadeh A; Van Dam K; Bastidas A; Berry RL; Patek CE; Van der Schueren B; Cassiman JJ; Tejpar S Int J Cancer; 2005 Mar; 114(2):202-8. PubMed ID: 15540161 [TBL] [Abstract][Full Text] [Related]
13. Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression. Wolfesberger B; Tonar Z; Witter K; Guija de Arespacohaga A; Skalicky M; Walter I; Thalhammer JG; Egger GF Res Vet Sci; 2008 Aug; 85(1):56-61. PubMed ID: 17888471 [TBL] [Abstract][Full Text] [Related]
14. Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations. Agaimy A; Wild V; Märkl B; Wachter DL; Hartmann A; Rosenwald A; Ihrler S Am J Surg Pathol; 2015 Sep; 39(9):1206-12. PubMed ID: 25929348 [TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor protein (WT1) in mammary myofibroblastoma: an immunohistochemical study. Magro G; Longo F; Salvatorelli L; Vecchio GM; Parenti R Acta Histochem; 2014 Jun; 116(5):905-10. PubMed ID: 24709316 [TBL] [Abstract][Full Text] [Related]
17. The role of Wilms' tumor genes. Hirose M J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307 [TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia. Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546 [TBL] [Abstract][Full Text] [Related]
19. The Wilms' tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. Wagner KD; Wagner N; Bondke A; Nafz B; Flemming B; Theres H; Scholz H FASEB J; 2002 Jul; 16(9):1117-9. PubMed ID: 12039855 [TBL] [Abstract][Full Text] [Related]
20. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor. Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]